WILSON TROY EDWARD 内部人交易：近期 SEC Form 4 交易
过去 18 个月，WILSON TROY EDWARD（CIK 1589597）在 4 家公司共报告 28 笔 SEC Form 4 内部人交易（最近一笔 2026-09-16）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-16 | PUMA BIOTECHNOLOGY, INC. (PBYI) | 董事 | 卖出 | 5,000 | $45,500 |
| 2026-08-24 | Kura Oncology, Inc. (KURA) | President and CEO | 买入 | 100,000 | $1.2M |
| 2026-08-17 | Kura Oncology, Inc. (KURA) | President and CEO | 买入 | 100,000 | $1.1M |
| 2026-06-15 | PUMA BIOTECHNOLOGY, INC. (PBYI) | 董事 | 买入 | 27,000 | $0 |
| 2026-06-15 | PUMA BIOTECHNOLOGY, INC. (PBYI) | 董事 | 卖出 | 10,800 | $77,760 |
| 2026-03-25 | Kura Oncology, Inc. (KURA) | President and CEO | 买入 | 6,103 | $37,533 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | 董事 | 卖出 | 65,091 | $0 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | 董事 | 卖出 | 13,711 | $0 |
| 2025-11-14 | Kura Oncology, Inc. (KURA) | President and CEO | 买入 | 182,500 | $0 |
| 2025-09-29 | Kura Oncology, Inc. (KURA) | President and CEO | 买入 | 182,500 | $0 |
| 2025-09-29 | Kura Oncology, Inc. (KURA) | President and CEO | 卖出 | 36,615 | $327,338 |
| 2025-09-09 | Avidity Biosciences, Inc. (RNA) | 董事 | 买入 | 14,500 | $180,960 |
| 2025-09-09 | Kura Oncology, Inc. (KURA) | President & CEO | 买入 | 50,000 | $410,000 |
| 2025-09-09 | Avidity Biosciences, Inc. (RNA) | 董事 | 卖出 | 14,500 | $725,000 |
| 2025-09-09 | Avidity Biosciences, Inc. (RNA) | 董事 | 卖出 | 15,000 | $750,000 |
| 2025-08-14 | Kura Oncology, Inc. (KURA) | President and CEO | 买入 | 36,506 | $213,560 |
| 2025-08-14 | Kura Oncology, Inc. (KURA) | President and CEO | 买入 | 13,494 | $89,600 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | 董事 | 买入 | 22,000 | $264,660 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | 董事 | 卖出 | 22,000 | $990,000 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | 董事 | 买入 | 7,500 | $93,600 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | 董事 | 卖出 | 7,500 | $337,500 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | 董事 | 卖出 | 15,000 | $675,000 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | 董事 | 卖出 | 15,000 | $675,000 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | 董事 | 卖出 | 17,777 | $799,965 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | 董事 | 卖出 | 17,777 | $799,965 |
来源：SEC Form 4 申报文件 · 截至 2026-09-16